SPDR S&P Biotech (XBI) 66.63 $XBI
The Top 3 Biotech ETFs on the Market
Brian Feroldi, The Motley Fool - Motley Fool - 1 hr 10 mins ago
Photo by Bill Brooks Flickr Creative Commons. Biotech investing is not for the faint of heart . The industry is chock-full of companies that don't even have revenue yet, let alone profits, which can lead to wild price swings. To make matters...
FBT: 104.32 (-1.22), XBI: 66.63 (-0.68), IBB: 325.46 (-3.09)
Look for Shares of SPDR S&P Biotech ETF to Potentially Pullback after Yesterday's 2.19% Rise
Comtex SmarTrend(R) - Tue Oct 27, 4:25PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $65.70 to a high of $67.35. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $67.30 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 66.63 (-0.68)
Downtrend Call Working As SPDR S&P Biotech ETF Stock Falls 9.0% (XBI)
Comtex SmarTrend(R) - Thu Oct 22, 9:43AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 4 weeks, SPDR S&P Biotech ETF has returned 9.01% as of today's recent price of $63.65.
XBI: 66.63 (-0.68)
Shareholder Alert: 4 Stocks Ready to Make a Move
ACCESSWIRE - Mon Oct 19, 11:17AM CDT
WINDSOR, ONTARIO / ACCESSWIRE / October 19, 2015 / The Wealthy Biotech Trader (or "WBT"
, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma, medical device and general healthcare stocks making news and subsequent market moves, is alerting traders about several trade ideas within the very healthy medical device sector.
LOXO: 23.38 (-0.50), XBI: 66.63 (-0.68), FORD: 1.21 (-0.01)
Watch for SPDR S&P Biotech ETF to Potentially Rebound After Falling 4.41% Yesterday
Comtex SmarTrend(R) - Tue Oct 13, 4:00PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $61.16 to a high of $65.20. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $61.38 on volume of 5.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 66.63 (-0.68)
SPDR S&P Biotech ETF Down 7.4% Since SmarTrend Downtrend Call (XBI)
Comtex SmarTrend(R) - Tue Oct 13, 11:54AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 3 weeks, SPDR S&P Biotech ETF has returned 7.38% as of today's recent price of $64.79.
XBI: 66.63 (-0.68)
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
Zacks Equity Research - Zacks Investment Research - Mon Oct 12, 8:30AM CDT
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
SPXU: 31.19 (+0.42), SH: 20.70 (+0.10), SDS: 19.67 (+0.20), XBI: 66.63 (-0.68), IBB: 325.46 (-3.09)
Protea: A High Quality Small-Cap to Ride Out Biotech's Drop
ACCESSWIRE - Mon Oct 12, 8:16AM CDT
REDONDO BEACH, CA / ACCESSWIRE / October 12, 2015 / The SPDR S&P Biotech ETF (ARCA: XBI) has fallen more than 20% over the past three months, which significantly outpaced the S&P 500's 4.7% fall over the same timeframe. With the House of Representatives subpoenaing Valeant Pharmaceuticals International Inc. (NYSE: VRX) for documents related to drug price increases, the market is concerned that the federal government may be stepping up its efforts to curb increases in drug prices.
VRX: 93.77 (-17.73), FMI: 22.42 (+0.26), XBI: 66.63 (-0.68), WAT: 127.80 (-0.76), VRX.TO: 122.04 (-26.19)
Juno Therapeutics (JUNO) Stock Could Lead the Way to a Biotech Bounce
at The Street - Fri Oct 09, 10:40AM CDT
We're watching the SPDR S&P Biotech ETF and its components for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 66.63 (-0.68), JUNO: 51.76 (+0.37)
Charting a Biotech Bounce
at The Street - Fri Oct 09, 10:10AM CDT
We're watching the SPDR S&P Biotech ETF for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 66.63 (-0.68), JUNO: 51.76 (+0.37)
7 Huge Mistakes Every ETF Investor Needs to Avoid
Eric Dutram - Zacks Investment Research - Fri Oct 09, 9:45AM CDT
These are some of the most common misconceptions about ETF investing, make sure you do not make the same mistakes!
SPY: 207.93 (-0.90), VXX: 18.83 (+0.25), GLD: 109.30 (-0.42), XBI: 66.63 (-0.68), IBB: 325.46 (-3.09), IAU: 11.02 (-0.04)
Correction in Health Care Stocks Remains in Full Force
at The Street - Thu Oct 08, 3:00PM CDT
Have we reached the point where something will be done about it?
CI: 134.04 (-1.51), ANTM: 139.15 (-2.19), HCA: 68.79 (+1.09), XBI: 66.63 (-0.68), UNH: 117.78 (-1.93), IBB: 325.46 (-3.09), XLV: 71.34 (-0.45)
3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical
Sean Williams, The Motley Fool - Motley Fool - Wed Oct 07, 7:03AM CDT
Source: Federal Reserve Bank of New York. With the exception of the last couple of weeks, the biotech sector has been a vast outperformer since the Great Recession. The broad-based S&P 500 has pretty much tripled since hitting its lows in...
BIIB: 290.51 (-3.21), VRTX: 124.74 (-1.43), XBI: 66.63 (-0.68), INCY: 117.53 (+0.50)
SPDR S&P Biotech ETF Rises 4.89% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 02, 4:07PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $60.45 to a high of $65.75. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $64.56 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 66.63 (-0.68)
Biotech ETFs Looking Attractive After Sell-Off
Sweta Killa - Zacks Investment Research - Thu Oct 01, 7:55AM CDT
The current slide in biotech sector made the stocks valuation attractive at the current levels.
BBP: 30.67 (+0.19), SBIO: 29.73 (-0.19), XBI: 66.63 (-0.68), IBB: 325.46 (-3.09)
Top ETF Stories of September
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 12:34PM CDT
Inside the top financial stories of September and their impact on the world of ETFs.
71.43 (+0.55), KRE: 42.83 (-0.96), BBC: 27.39 (-0.31), SBIO: 29.73 (-0.19), VRX: 93.77 (-17.73), EWG: 27.11 (+0.06), IAI: 41.07 (-0.58), REM: 9.93 (-0.02), XBI: 66.63 (-0.68), EDV: 118.00 (+1.22), IBB: 325.46 (-3.09), GDX: 14.96 (-0.16)
Notable ETF Inflow Detected - XBI, ZIOP, ACHN, ZFGN
ETFChannel.com - Wed Sep 30, 9:52AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF where we have detected an approximate $186.0 million dollar inflow -- that's a 10.1% increase...
XBI: 66.63 (-0.68)
The Top 3 Biotech ETFs on the Market
Brian Feroldi, The Motley Fool - Motley Fool - 1 hr 10 mins ago
Photo by Bill Brooks Flickr Creative Commons. Biotech investing is not for the faint of heart . The industry is chock-full of companies that don't even have revenue yet, let alone profits, which can lead to wild price swings. To make matters...
FBT: 104.32 (-1.22), XBI: 66.63 (-0.68), IBB: 325.46 (-3.09)
Look for Shares of SPDR S&P Biotech ETF to Potentially Pullback after Yesterday's 2.19% Rise
Comtex SmarTrend(R) - Tue Oct 27, 4:25PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $65.70 to a high of $67.35. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $67.30 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 66.63 (-0.68)
Downtrend Call Working As SPDR S&P Biotech ETF Stock Falls 9.0% (XBI)
Comtex SmarTrend(R) - Thu Oct 22, 9:43AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 4 weeks, SPDR S&P Biotech ETF has returned 9.01% as of today's recent price of $63.65.
XBI: 66.63 (-0.68)
Shareholder Alert: 4 Stocks Ready to Make a Move
ACCESSWIRE - Mon Oct 19, 11:17AM CDT
WINDSOR, ONTARIO / ACCESSWIRE / October 19, 2015 / The Wealthy Biotech Trader (or "WBT"
, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma, medical device and general healthcare stocks making news and subsequent market moves, is alerting traders about several trade ideas within the very healthy medical device sector. LOXO: 23.38 (-0.50), XBI: 66.63 (-0.68), FORD: 1.21 (-0.01)
Watch for SPDR S&P Biotech ETF to Potentially Rebound After Falling 4.41% Yesterday
Comtex SmarTrend(R) - Tue Oct 13, 4:00PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $61.16 to a high of $65.20. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $61.38 on volume of 5.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 66.63 (-0.68)
SPDR S&P Biotech ETF Down 7.4% Since SmarTrend Downtrend Call (XBI)
Comtex SmarTrend(R) - Tue Oct 13, 11:54AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 3 weeks, SPDR S&P Biotech ETF has returned 7.38% as of today's recent price of $64.79.
XBI: 66.63 (-0.68)
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
Zacks Equity Research - Zacks Investment Research - Mon Oct 12, 8:30AM CDT
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
SPXU: 31.19 (+0.42), SH: 20.70 (+0.10), SDS: 19.67 (+0.20), XBI: 66.63 (-0.68), IBB: 325.46 (-3.09)
Protea: A High Quality Small-Cap to Ride Out Biotech's Drop
ACCESSWIRE - Mon Oct 12, 8:16AM CDT
REDONDO BEACH, CA / ACCESSWIRE / October 12, 2015 / The SPDR S&P Biotech ETF (ARCA: XBI) has fallen more than 20% over the past three months, which significantly outpaced the S&P 500's 4.7% fall over the same timeframe. With the House of Representatives subpoenaing Valeant Pharmaceuticals International Inc. (NYSE: VRX) for documents related to drug price increases, the market is concerned that the federal government may be stepping up its efforts to curb increases in drug prices.
VRX: 93.77 (-17.73), FMI: 22.42 (+0.26), XBI: 66.63 (-0.68), WAT: 127.80 (-0.76), VRX.TO: 122.04 (-26.19)
Juno Therapeutics (JUNO) Stock Could Lead the Way to a Biotech Bounce
at The Street - Fri Oct 09, 10:40AM CDT
We're watching the SPDR S&P Biotech ETF and its components for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 66.63 (-0.68), JUNO: 51.76 (+0.37)
Charting a Biotech Bounce
at The Street - Fri Oct 09, 10:10AM CDT
We're watching the SPDR S&P Biotech ETF for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 66.63 (-0.68), JUNO: 51.76 (+0.37)
7 Huge Mistakes Every ETF Investor Needs to Avoid
Eric Dutram - Zacks Investment Research - Fri Oct 09, 9:45AM CDT
These are some of the most common misconceptions about ETF investing, make sure you do not make the same mistakes!
SPY: 207.93 (-0.90), VXX: 18.83 (+0.25), GLD: 109.30 (-0.42), XBI: 66.63 (-0.68), IBB: 325.46 (-3.09), IAU: 11.02 (-0.04)
Correction in Health Care Stocks Remains in Full Force
at The Street - Thu Oct 08, 3:00PM CDT
Have we reached the point where something will be done about it?
CI: 134.04 (-1.51), ANTM: 139.15 (-2.19), HCA: 68.79 (+1.09), XBI: 66.63 (-0.68), UNH: 117.78 (-1.93), IBB: 325.46 (-3.09), XLV: 71.34 (-0.45)
3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical
Sean Williams, The Motley Fool - Motley Fool - Wed Oct 07, 7:03AM CDT
Source: Federal Reserve Bank of New York. With the exception of the last couple of weeks, the biotech sector has been a vast outperformer since the Great Recession. The broad-based S&P 500 has pretty much tripled since hitting its lows in...
BIIB: 290.51 (-3.21), VRTX: 124.74 (-1.43), XBI: 66.63 (-0.68), INCY: 117.53 (+0.50)
SPDR S&P Biotech ETF Rises 4.89% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 02, 4:07PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $60.45 to a high of $65.75. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $64.56 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 66.63 (-0.68)
Biotech ETFs Looking Attractive After Sell-Off
Sweta Killa - Zacks Investment Research - Thu Oct 01, 7:55AM CDT
The current slide in biotech sector made the stocks valuation attractive at the current levels.
BBP: 30.67 (+0.19), SBIO: 29.73 (-0.19), XBI: 66.63 (-0.68), IBB: 325.46 (-3.09)
Top ETF Stories of September
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 12:34PM CDT
Inside the top financial stories of September and their impact on the world of ETFs.
71.43 (+0.55), KRE: 42.83 (-0.96), BBC: 27.39 (-0.31), SBIO: 29.73 (-0.19), VRX: 93.77 (-17.73), EWG: 27.11 (+0.06), IAI: 41.07 (-0.58), REM: 9.93 (-0.02), XBI: 66.63 (-0.68), EDV: 118.00 (+1.22), IBB: 325.46 (-3.09), GDX: 14.96 (-0.16) Notable ETF Inflow Detected - XBI, ZIOP, ACHN, ZFGN
ETFChannel.com - Wed Sep 30, 9:52AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF where we have detected an approximate $186.0 million dollar inflow -- that's a 10.1% increase...
XBI: 66.63 (-0.68)
